Author

Hilal Bal

Bilkent UniversityORCID 0000-0003-1668-6070Unclaimed ORCID profile · follow to get notified of new preprints

Biology Disciplines

Click to filter author papers

Signature Assays, Organisms & Methods

Click to filter · or open tag

Assay:bulk RNA-seq· 1 Research Focus:cancer & tumor microenvironment· 1 Approach:experimental assay· 1 Organism:human· 1

Frequent Co-Authors

Aynur IşıkiD· 1 shared Ayşegül ÜneriD· 1 shared Aytekin AkyoliD· 1 shared Besim ÖğretmeniD· 1 shared Bürge UlukaniD· 1 shared Daniel GautheretiD· 1 shared Denis ThieffryiD· 1 shared Kim‐Tuyen Huynh‐Dam· 1 shared

Activity by Year

2024-2024 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 45 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperCancer Biology

Aynur IşıkORCID

Mutual co-authors in cluster

Author profile →

1 paper

Recent·Most cited

Cancer BiologyCell Death and DiseasePeer-reviewedJun 15, 2024

Targeting LINC00152 activates cAMP/Ca2+/ferroptosis axis and overcomes tamoxifen resistance in ER+ breast cancer

Özge Saatci, Rashedul Alam, Kim‐Tuyen Huynh‐Dam…·Özgür Şahin

This study identifies LINC00152 as a driver of tamoxifen resistance in ER+ breast cancer by inhibiting ferroptosis, and shows that targeting LINC00152 restores sensitivity to tamoxifen.

42 citationstop 3%

humanbulk RNA-seq

𝕏 PostBluesky